galantamine has been researched along with Chronic Illness in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerasimenko, MIu; P'ianzina, AV | 1 |
| Khan, A; Lindenmayer, JP | 1 |
| Carroll, KM; Poling, J; Sofuoglu, M; Waters, AJ | 1 |
| Hong, JM; Huh, K; Lee, JS; Lim, TS; Shin, DH | 1 |
| Farlow, M; Hock, C; Schwalen, S; van Baelen, B; Wilkinson, DG | 1 |
| Björner, A; Eriksson, L; Norén, U; Sonesson, O | 1 |
| Schneeweiss, S; Thacker, EL | 1 |
| Kim, YH; Lee, BJ; Lee, JG; Lee, SW | 1 |
5 trial(s) available for galantamine and Chronic Illness
| Article | Year |
|---|---|
[Microcirculatory effects of fluctophoresis series in patient with moderate chronic periodontal disease].
Topics: Adult; Aged; Blood Vessels; Chronic Disease; Electrophoresis; Female; Galantamine; Heme; Humans; Laser-Doppler Flowmetry; Male; Methylhydrazines; Microcirculation; Middle Aged; Periodontal Diseases; Periodontium | 2013 |
Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cognition Disorders; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Injections, Intramuscular; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia | 2011 |
Galantamine improves sustained attention in chronic cocaine users.
Topics: Affect; Attention; Chronic Disease; Cocaine-Related Disorders; Cognition; Delayed-Action Preparations; Double-Blind Method; Female; Galantamine; Humans; Male; Neuropsychological Tests; Nootropic Agents; Placebos; Treatment Outcome | 2011 |
Galantamine administration in chronic post-stroke aphasia.
Topics: Adult; Aged; Aphasia; Brain; Chronic Disease; Female; Galantamine; Humans; Language Tests; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Nootropic Agents; Speech; Stroke; Young Adult | 2012 |
A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chronic Disease; Cognition; Cognition Disorders; Color Perception; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Mental Recall; Mental Status Schedule; Middle Aged; Nootropic Agents; Recognition, Psychology; Schizophrenia; Treatment Outcome | 2007 |
3 other study(ies) available for galantamine and Chronic Illness
| Article | Year |
|---|---|
Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months.
Topics: Aged; Alzheimer Disease; Behavior; Cholinesterase Inhibitors; Chronic Disease; Clinical Trials, Phase III as Topic; Cognition; Female; Galantamine; Humans; Male; Nootropic Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Galantamine added to antipsychotic treatment in chronic schizophrenia: cognitive improvement?
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Chronic Disease; Cognition Disorders; Drug Therapy, Combination; Galantamine; Humans; Neuropsychological Tests; Pilot Projects; Schizophrenia; Severity of Illness Index | 2006 |
Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Chronic Disease; Cross-Over Studies; Donepezil; Female; Galantamine; Humans; Indans; Logistic Models; Male; Phenylcarbamates; Piperidines; Respiratory Tract Diseases; Rivastigmine | 2006 |